NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. The 2014 Pathology Working Group Report

Sale, 2004, Pathology of hematopoietic cell transplantation, 286 Shulman, 1980, Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients, Am J Med, 69, 204, 10.1016/0002-9343(80)90380-0 Snover, 1990, The pathology of acute GVHD, 337 Shulman, 1990, Pathology of chronic GVHD, 587 Wagner, 2003, Pathology and pathogenesis of cutaneous graft-vs.-host disease, 229 Liu, 2003, Graft-versus-host disease of the liver, 257 Heymer, 2002 Ziemer, 2013, Graft-versus-host disease of the skin and adjacent mucous membranes, J German Soc Dermatol, 11, 477 Flowers, 2011, Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria, Blood, 117, 3214, 10.1182/blood-2010-08-302109 Shulman, 2006, Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report, Biol Blood Marrow Transplant, 12, 31, 10.1016/j.bbmt.2005.10.023 Nishiwaki, 2009, Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease, Blood, 114, 3113, 10.1182/blood-2009-03-209635 Levine, 2013, Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality, Blood, 122, 1505, 10.1182/blood-2013-02-485813 Biedermann, 2002, Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease, Lancet, 359, 2078, 10.1016/S0140-6736(02)08907-9 Dietrich, 2013, Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment, Biol Blood Marrow Transplant, 19, 22, 10.1016/j.bbmt.2012.09.018 Luft, 2011, Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system, Blood, 118, 1685, 10.1182/blood-2011-02-334821 Palomo, 2010, Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation, Biol Blood Marrow Transplant, 16, 985, 10.1016/j.bbmt.2010.02.008 Schmid, 2014, Endothelial dysfunction and altered mechanical and structural properties of resistance arteries in a murine model of GVHD, Biol Blood Marrow Transplant, 20, 1493, 10.1016/j.bbmt.2014.05.002 Filipovich, 2005, National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report, Biol Blood Marrow Transplant, 11, 945, 10.1016/j.bbmt.2005.09.004 Jacobsohn, 2001, Clinical importance of confirming or excluding the diagnosis of chronic graft-versus-host disease, Bone Marrow Transplant, 28, 1047, 10.1038/sj.bmt.1703278 Bolanos-Meade, 2007, Grover's Disease after Bone Marrow Transplantation, Biol Blood Marrow Transplant, 13, 1116, 10.1016/j.bbmt.2007.06.002 Patel, 2009, Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients, Biol Blood Marrow Transplant, 15, 370, 10.1016/j.bbmt.2008.12.491 Ponec, 1999, Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation, Gastrointest Endosc, 49, 612, 10.1016/S0016-5107(99)70390-1 Shulman, 1988, A coded histologic study of hepatic graft-versus-host disease after human bone marrow transplantation, Hepatology, 8, 463, 10.1002/hep.1840080305 Stechschulte, 1990, Secondary biliary cirrhosis as a consequence of graft-versus-host disease, Gastroenterology, 98, 223, 10.1016/0016-5085(90)91315-W Strasser, 2000, Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis, Hepatology, 32, 1265, 10.1053/jhep.2000.20067 Hubscher, 1991, Vanishing bile-duct syndrome following liver transplantation–is it reversible?, Transplantation, 51, 1004, 10.1097/00007890-199105000-00014 Shulman, 1980, An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation, Gastroenterology, 79, 1178, 10.1016/0016-5085(80)90911-7 Green, 1996, Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents, Gastroenterology, 111, 193, 10.1053/gast.1996.v111.pm8698199 Barshes, 2005, Liver transplantation for severe hepatic graft-versus-host disease: an analysis of aggregate survival data, Liver Transpl, 11, 525, 10.1002/lt.20389 Balistreri, 2003, What every hepatologist needs to know about pediatric liver disease, 143 Lerner, 1974, Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors, Transplant Proc, 6, 367 Hill, 2014, Hepatitis due to human herpesvirus 6 after hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, 20, S228, 10.1016/j.bbmt.2013.12.385 Kamble, 2006, Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, 12, 506, 10.1016/j.bbmt.2006.01.004 Sucak, 2008, The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated?, Bone Marrow Transplant, 42, 461, 10.1038/bmt.2008.193 Lefkowitch, 2006, Ground-glass, polyglucosan-like hepatocellular inclusions: a “new” diagnostic entity, Gastroenterology, 131, 713, 10.1053/j.gastro.2006.07.006 Wisell, 2006, Glycogen pseudoground glass change in hepatocytes, Am J Surg Pathol, 30, 1085, 10.1097/01.pas.0000208896.92988.fc Bejarano, 2006, Liver glycogen bodies: ground-glass hepatocytes in transplanted patients, Virchows Archiv, 449, 539, 10.1007/s00428-006-0286-2 O'Shea, 2007, Lafora-like ground-glass inclusions in hepatocytes of pediatric patients: a report of two cases, Pediatr Dev Pathol, 10, 351, 10.2350/06-12-01948.1 Lunz, 2001, Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs, Am J Pathol, 158, 1379, 10.1016/S0002-9440(10)64089-8 Malard, 2014, Increased Th17/Treg ratio in chronic liver GVHD, Bone Marrow Transplant, 49, 539, 10.1038/bmt.2013.215 Ali, 2010, Frequent expression of C4d in hepatic graft-versus-host disease: potential clue for diagnosis and distinguishing acute and chronic form, Transplant Immunol, 23, 77, 10.1016/j.trim.2010.03.002 Akpek, 2002, Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion, Blood, 100, 3903, 10.1182/blood-2002-03-0857 Lefkowitch, 1993, Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group, Gastroenterology, 104, 595, 10.1016/0016-5085(93)90432-C Cooksley, 1995, Fibrosing cholestatic hepatitis and HBV after bone marrow transplantation, Biomed Pharmacother, 49, 117, 10.1016/0753-3322(96)82604-7 Evans, 2015, Fibrosing cholestatic hepatitis C following hematopoietic cell transplantation: report of three fatal cases, Am J Surg Pathol, 39, 212, 10.1097/PAS.0000000000000345 Barba, 2012, Incidence, characteristics and risk factors of marked hyperbilirubinemia after allogeneic hematopoietic cell transplantation with reduced-intensity conditioning, Bone Marrow Transplant, 47, 1343, 10.1038/bmt.2012.25 Kagoya, 2011, Hyperbilirubinemia after hematopoietic stem cell transplantation: comparison of clinical and pathologic findings in 41 autopsied cases, Clin Transplant, 25, E552, 10.1111/j.1399-0012.2011.01498.x Arora, 2011, Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis, Blood, 117, 6714, 10.1182/blood-2010-12-323824 Gooley, 2005, Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation, Hepatology, 41, 345, 10.1002/hep.20529 Leisenring, 2006, An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens, Blood, 108, 749, 10.1182/blood-2006-01-0254 Pidala, 2013, Analysis of gastrointestinal and hepatic chronic grant-versus-host disease manifestations on major outcomes: a chronic graft-versus-host disease consortium study, Biol Blood Marrow Transplant, 19, 784, 10.1016/j.bbmt.2013.02.001 Quaglia, 2007, Histopathology of graft versus host disease of the liver, Histopathology, 50, 727, 10.1111/j.1365-2559.2007.02679.x Duarte, 2005, Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver, Biol Blood Marrow Transplant, 11, 805, 10.1016/j.bbmt.2005.06.008 Akpek, 2003, Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study, Biol Blood Marrow Transplant, 9, 46, 10.1053/bbmt.2003.49999 Epstein, 1980, The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients, Gastroenterology, 78, 764, 10.1016/0016-5085(80)90681-2 Gomez, 2014, Clinicopathologic assessment of grade 1 acute gastrointestinal graft versus host disease: diagnostic threshold of crypt apoptotic bodies, Mod Pathol, 27, 203A Lin, 2013, Is the presence of 6 or fewer crypt apoptotic bodies sufficient for diagnosis of graft versus host disease? A decade of experience at a single institution, Am J Surg Pathol, 37, 539, 10.1097/PAS.0b013e318272c62a Cardona, 2012, An analysis of the application and reproducibility of the NIH consensus guidelines for the histologic diagnosis of gastrointestinal acute graft versus host disease, Mod Pathol, 25, 155 Nguyen, 2009, Mycophenolic acid (cellcept and myofortic) induced injury of the upper GI tract, Am J Surg Pathol, 33, 1355, 10.1097/PAS.0b013e3181a755bd Al-Absi, 2010, Patterns of injury in mycophenolate mofetil-related colitis, Transplant Proc, 42, 3591, 10.1016/j.transproceed.2010.08.066 Papadimitriou, 2003, Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern, Int J Surg Pathol, 11, 295, 10.1177/106689690301100406 Parfitt, 2008, Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes, Am J Surg Pathol, 32, 1367, 10.1097/PAS.0b013e31816bf3fe Patra, 2012, Mycophenolate mofetil-induced colitis with graft versus host disease-like features in a liver transplant recipient, Indian J Pathol Microbiol, 55, 506, 10.4103/0377-4929.107792 Selbst, 2009, Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil, Mod Pathol, 22, 737, 10.1038/modpathol.2009.44 Daneshpouy, 2002, Activated eosinophils in upper gastrointestinal tract of patients with graft-versus-host disease, Blood, 99, 3033, 10.1182/blood.V99.8.3033 Shealy, 2014, The role of eosinophils and neuroendocrine cell nests in the assessment of gastrointestinal biopsies in bone marrow transplant patients, Mod Pathol, 2014, 203A Star, 2013, Histologic features in colon biopsies can discriminate mycophenolate from GVHD-induced colitis, Am J Surg Pathol, 37, 1319, 10.1097/PAS.0b013e31829ab1ef Leino, 2012, Can we distinguish mycophenolate-induced colitis from colonic graft-versus-host diseaes?, Mod Pathol, 25, 167 Welch, 2006, Gastric graft-versus-host disease revisited: does proton pump inhibitor therapy affect endoscopic gastric biopsy interpretation?, Am J Surg Pathol, 30, 444, 10.1097/00000478-200604000-00003 Ferrara, 2011, Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease, Blood, 118, 6702, 10.1182/blood-2011-08-375006 Melson, 2007, Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease, Am J Hematol, 82, 881, 10.1002/ajh.20976 Herrera, 2011, Cord colitis syndrome in cord-blood stem-cell transplantation, N Engl J Med, 365, 815, 10.1056/NEJMoa1104959 Milano, 2014, Late onset colitis after cord blood transplant is consistent with graft-versus-host disease: results of a blinded histopathological review, Biol Blood Marrow Transplant, 20, 1008, 10.1016/j.bbmt.2014.03.020 Shimoji, 2013, Evaluating the association between histological manifestations of cord colitis syndrome with GVHD, Bone Marrow Transplant, 48, 1249, 10.1038/bmt.2013.44 Crowell, 2013, Endoscopy in the diagnosis of intestinal graft-versus-host disease: is lower endoscopy with biopsy as effective in diagnosis as upper endoscopy combined with lower endoscopy?, Pediatr Blood Cancer, 60, 1798, 10.1002/pbc.24634 Shidham, 2003, Colon biopsies for evaluation of acute graft-versus-host disease (A-GVHD) in allogeneic bone marrow transplant patients, BMC Gastroenterol, 3, 5, 10.1186/1471-230X-3-5 Andrulis, 2012, Loss of endothelial thrombomodulin predicts response to steroid therapy and survival in acute intestinal graft-versus-host disease, Haematologica, 97, 1674, 10.3324/haematol.2011.061051 Kreisel, 2012, Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients, Bone Marrow Transplant, 47, 430, 10.1038/bmt.2011.137 Abraham, 2014, Clinical severity scores in gastrointestinal graft-versus-host disease, Transplantation, 97, 965, 10.1097/01.TP.0000438209.50089.60 Nydegger, 2007, Diagnosis of gastrointestinal graft-versus-host disease–is rectal biopsy enough?, Pediatr Blood Cancer, 48, 561, 10.1002/pbc.20924 Ross, 2008, Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies, Am J Gastroenterol, 103, 982, 10.1111/j.1572-0241.2007.01639.x Roy, 1991, Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease, Transplantation, 51, 642, 10.1097/00007890-199103000-00019 Thompson, 2006, Prospective endoscopic evaluation for gastrointestinal graft-versus-host disease: determination of the best diagnostic approach, Bone Marrow Transplant, 38, 371, 10.1038/sj.bmt.1705453 Yeh, 2004, Gastric bleeding due to graft-vs-host disease: discrepancy between endoscopic and histologic assessment, Am J Clin Pathol, 122, 919, 10.1309/23DAL9F6P74XWJHL Lord, 2011, Blood and gastric FOXP3+ T cells are not decreased in human gastric graft-versus-host disease, Biol Blood Marrow Transplant, 17, 486, 10.1016/j.bbmt.2010.09.015 Hymes, 2006, Cutaneous manifestations of chronic graft-versus-host disease, Biol Blood Marrow Transplant, 12, 1101, 10.1016/j.bbmt.2006.08.043 Hillen, 2014, Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease, J Eur Acad Dermatol Venereol Ziemer, 2014, Histopathological diagnosis of graft-versus-host disease of the skin - an interobserver comparison, J Eur Acad Dermatol Venereol, 28, 915, 10.1111/jdv.12215 Horn, 1994, Reappraisal of histologic features of the acute cutaneous graft-versus-host reaction based on an allogeneic rodent model, J Invest Dermatol, 103, 206, 10.1111/1523-1747.ep12392774 Fitzpatrick, 2000, Patterns in dermatopathology, 113 Marra, 2004, Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease, J Am Acad Dermatol, 51, 543, 10.1016/j.jaad.2004.02.019 Li, 2012, Keratinocyte dysplasia in hematopoietic stem cell transplantation recipients in the day-28-to-84 posttransplantation period, Biol Blood Marrow Transplant, 18, 1281, 10.1016/j.bbmt.2012.02.001 Vassallo, 2004, Normal-looking skin in oncohaematological patients after allogenic bone marrow transplantation is not normal, Br J Dermatol, 151, 579, 10.1111/j.1365-2133.2004.06072.x White, 2006, Koebnerizing sclerodermatous graft-versus-host disease caused by donor lymphocyte infusion and interferon-alpha, Br J Dermatol, 155, 621, 10.1111/j.1365-2133.2006.07404.x Janin, 1994, Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 cases, Ann Intern Med, 120, 993, 10.7326/0003-4819-120-12-199406150-00004 Kaffenberger, 2014, Graft-versus-host disease-associated angiomatosis: a clinicopathologically distinct entity, J Am Acad Dermatol, 71, 745, 10.1016/j.jaad.2014.05.034 Greinix, 1998, Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease, Blood, 92, 3098, 10.1182/blood.V92.9.3098 Nash, 2007, High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study, Blood, 110, 1388, 10.1182/blood-2007-02-072389 Verrecchia, 2007, Skin involvement in scleroderma–where histological and clinical scores meet, Rheumatology, 46, 833, 10.1093/rheumatology/kel451 Fleming, 2009, Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis, PLoS One, 4, e6203, 10.1371/journal.pone.0006203 Aschwanden, 2011, Nail fold capillaroscopy differs widely between systemic sclerosis and chronic graft vs host disease of the skin, Rheumatology, 50, 1168, 10.1093/rheumatology/ker125 Hofstee, 2013, Nailfold capillary abnormalities in sclerodermatous chronic GVHD, Bone Marrow Transplant, 48, 1574, 10.1038/bmt.2013.106 Sale, 1981, Oral and ophthalmic pathology of graft versus host disease in man: predictive value of the lip biopsy, Hum Pathol, 12, 1022, 10.1016/S0046-8177(81)80260-2 Nakhleh, 1989, Significance of mucosal vs salivary gland changes in lip biopsies in the diagnosis of chronic graft-vs-host disease, Arch Pathol Lab Med, 113, 932 Horn, 1995, The significance of oral mucosal and salivary gland pathology after allogeneic bone marrow transplantation, Arch Dermatol, 131, 964, 10.1001/archderm.131.8.964 Soares, 2013, The impact of morphological and immunohistological changes in minor salivary glands on the health of the oral cavity in HSCT patients, Bone Marrow Transplant, 48, 1525, 10.1038/bmt.2013.105 Alborghetti, 2005, Late effects of chronic graft-vs.-host disease in minor salivary glands, J Oral Pathol Med, 34, 486, 10.1111/j.1600-0714.2005.00347.x Imanguli, 2010, Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation, Biol Blood Marrow Transplant, 16, 1362, 10.1016/j.bbmt.2010.03.023 Devic, 2014, Proteomic analysis of saliva from patients with oral chronic graft-versus-host disease, Biol Blood Marrow Transplant, 20, 1048, 10.1016/j.bbmt.2014.03.031 Jagasia, 2015, National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report, Biol Blood Marrow Transplant, 21, 389, 10.1016/j.bbmt.2014.12.001 Curtis, 2005, Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study, Blood, 105, 3802, 10.1182/blood-2004-09-3411 Treister, 2005, Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, 11, 721, 10.1016/j.bbmt.2005.06.002 Spiryda, 2003, Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment, Biol Blood Marrow Transplant, 9, 760, 10.1016/j.bbmt.2003.08.001 Hirst, 1983, The eye in bone marrow transplantation. I. Clinical study, Arch Ophthalmol, 101, 580, 10.1001/archopht.1983.01040010580010 Jabs, 1983, The eye in bone marrow transplantation. II. Histopathology, Arch Ophthalmol, 101, 585, 10.1001/archopht.1983.01040010585011 Ogawa, 2003, Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease, Invest Ophthalmol Vis Sci, 44, 1888, 10.1167/iovs.02-0699 West, 1991, Ocular surface and lacrimal disturbances in chronic graft-versus-host disease: the role of conjunctival biopsy, Aust N Z J Ophthalmol, 19, 187, 10.1111/j.1442-9071.1991.tb00658.x Jabs, 1989, The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease, Arch Ophthal, 107, 1343, 10.1001/archopht.1989.01070020413046 Saito, 2002, Ocular manifestation of acute graft-versus-host disease after allogeneic peripheral blood stem cell transplantation, Int J Hematol, 75, 332, 10.1007/BF02982052 Kim, 2004, Ocular graft versus host disease, 879 Yousem, 1996, Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group, J Heart Lung Transplant, 15, 1 Saito, 1997, Bronchiolitis obliterans with pemphigus vulgaris and Castleman's disease of hyaline-vascular type: an autopsy case analyzed by computer-aided 3-D reconstruction of the airway lesions, Hum Pathol, 28, 1310, 10.1016/S0046-8177(97)90208-2 Colby, 1998, Bronchiolitis Pathologic considerations, Am J Clin Pathol, 109, 101, 10.1093/ajcp/109.1.101 King, 1998, Bronchiolitis, 645 Uhlving, 2015, Biopsy-verified bronchiolitis obliterans and other non-infectious lung pathologies after allogeneic hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, 21, 531, 10.1016/j.bbmt.2014.12.004 Holbro, 2013, Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, 19, 973, 10.1016/j.bbmt.2013.03.017 Barker, 2014, Obliterative bronchiolitis, N Engl J Med, 370, 1820, 10.1056/NEJMra1204664 Galban, 2014, Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, 20, 1592, 10.1016/j.bbmt.2014.06.014 Freudenberger, 2003, Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants, Blood, 102, 3822, 10.1182/blood-2002-06-1813 Chang, 2007, Spectrum of renal pathology in hematopoietic cell transplantation: a series of 20 patients and review of the literature, Clin J Am Soc Nephrol, 2, 1014, 10.2215/CJN.01700407 Abboud, 2012, Chronic kidney diseases in long-term survivors after allogeneic hematopoietic stem cell transplantation: monitoring and management guidelines, Sem Hematol, 49, 73, 10.1053/j.seminhematol.2011.10.008 Niscola, 2013, The management of membranous glomerulopathy in allogeneic stem cells transplantation: updated literature, Cardiovasc Hematol Agents Med Chem, 11, 67, 10.2174/1871525711311010011 Hingorani, 2014, Urinary cytokines after HCT: evidence for renal inflammation in the pathogenesis of proteinuria and kidney disease, Bone Marrow Transplant, 49, 403, 10.1038/bmt.2013.197 Hingorani, 2015, Urinary elafin and kidney injury in hematopoietic cell transplant recipients, Clin J Am Soc Nephrol, 10, 12, 10.2215/CJN.01840214 Ferrara, 2000, Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors, J Hematother Stem Cell Res, 9, 299, 10.1089/15258160050079407 Rao, 2005, Nephrotic syndrome in patients with peripheral blood stem cell transplant, Am J Kidney Dis, 45, 780, 10.1053/j.ajkd.2005.01.003 Brukamp, 2006, Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?, Clin J Am Soc Nephrol, 1, 685, 10.2215/CJN.00380705 Chan, 2004, IgA nephropathy complicating graft-versus-host disease, another nephropathy causing nephrotic syndrome after bone marrow transplantation, Histopathology, 45, 648, 10.1111/j.1365-2559.2004.01958.x Chien, 2000, Nephrotic syndrome in a bone marrow transplant recipient without chronic graft-versus-host disease, J Formos Med Assoc, 99, 503 Nouri-Majelan, 2005, Antineutrophil cytoplasmic antibody-associated glomerulonephritis in chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation, Transplant Proc, 37, 3213, 10.1016/j.transproceed.2005.07.031 Oliveira, 1999, Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal, Bone Marrow Transplant, 23, 99, 10.1038/sj.bmt.1701527 Suehiro, 2002, Diffuse proliferative glomerulonephritis after bone marrow transplantation, Clin Nephrol, 58, 231, 10.5414/CNP58231 El-Seisi, 2003, Renal pathology at autopsy in patients who died after hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, 9, 683, 10.1016/S1083-8791(03)00243-X Kusumi, 2008, Postmortem examination of the kidney in allogeneic hematopoietic stem cell transplantation recipients: possible involvement of graft-versus-host disease, Int J Hematol, 87, 225, 10.1007/s12185-008-0026-2 Allen, 2009, Dermatomyositis-like muscle pathology in patients with chronic graft-versus-host disease, Muscle Nerve, 40, 643, 10.1002/mus.21353 Montoro, 2012, Polymyositis after donor lymphocyte infusion, Int J Hematol, 96, 386, 10.1007/s12185-012-1144-4 Rackley, 2005, Cardiac manifestations of graft-versus-host disease, Biol Blood Marrow Transplant, 11, 773, 10.1016/j.bbmt.2005.07.002 Stift, 2014, Consensus on the histopathological evaluation of liver biopsies from patients following allogeneic hematopoietic cell transplantation, Virchows Archiv, 464, 175, 10.1007/s00428-013-1528-8